ロード中...
Rituximab Twice Weekly for Refractory Thrombotic Thrombocytopenic Purpura in a Critically Ill Patient with Acute Respiratory Distress Syndrome
Thrombotic thrombocytopenic purpura (TTP) is a rare, serious, life-threatening disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and hypercoagulability. The etiology is a deficiency of ADAMTS13 which is usually caused by acquired antibodies. Plasma exchange and steroids i...
保存先:
| 出版年: | Case Rep Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7098356/ https://ncbi.nlm.nih.gov/pubmed/32231537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000505236 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|